ZUG, Switzerland and BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial ...

Neoadjuvant immunotherapy could considerably improve long-term outcomes and quality of life for patients with desmoplastic ...

Researchers have developed a highly sensitive light-based sensor that can detect extremely low concentrations of cancer ...

A new CRISPR-powered light sensor can detect the faintest whispers of cancer in a single drop of blood.

Researchers have developed a highly sensitive light-based sensor that can detect extremely low concentrations of cancer biomarkers in the ...

Researchers have developed a highly sensitive light-based sensor that can detect extremely low concentrations of cancer ...

The most detailed atlas of tumour cells from the deadliest form of pancreatic cancer has been developed by an global team of researchers ...

Mass General Brigham and Dana-Farber Cancer Institute researchers have found that a virus-based therapy boosts survival in glioblastoma patients.

A gene therapy that patients breathe in has been found to shrink lung tumours by inserting immune-boosting genes into ...

Researchers used CRISPR gene editing to selectively kill cancer cells with amplified oncogenes. In animal and cellular models ...

In a lab-grown cell study focused on potential new treatment targets for halting the spread of most pancreatic cancers, Johns ...

New treatment approach could be an effective and less costly alternative to traditional immunotherapies ...